Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma

Overview of attention for article published in Biomarker Research, April 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 3,604 followers.

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma #lymphoma #lymsm https://t.co/O7RZLhCS7A

06 Apr 2022

Reply Repost Favourite

RT @PaperbirdsM: New article: Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymph…

05 Apr 2022

Reply Repost Favourite

New article: Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma https://t.co/OQGTCoQC2m #CLL #leusm #hematology

05 Apr 2022

Reply Repost Favourite

New article: Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma https://t.co/9NX5Bh2tgD #MCL #lymsm #hematology https://t.co/0jbU2paWA6

05 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.